Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy.

[1]  D. Larkin.  Corneal allograft rejection. , 1994, The British journal of ophthalmology.

[2]  P. Watson,et al.  Corticosteroids in corneal graft rejection. Oral versus single pulse therapy. , 1991, Ophthalmology.

[3]  K. Copeland,et al.  Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. , 1990, Clinical chemistry.

[4]  M. Belin,et al.  Topical cyclosporine in high-risk corneal transplants. , 1989, Ophthalmology.

[5]  J. Hill.  The use of cyclosporine in high-risk keratoplasty. , 1989, American journal of ophthalmology.

[6]  R. Maske,et al.  AN ANIMAL MODEL FOR CORNEAL GRAFT REJECTION IN HIGH‐RISK KERATOPLASTY , 1988, Transplantation.

[7]  T. Billiar,et al.  Cyclosporine-induced hepatotoxicity: a microassay by hepatocytes in tissue culture. , 1988, Transplantation proceedings.

[8]  B. Ryffel,et al.  Histopathology of cyclosporine nephrotoxicity. , 1988, Transplantation proceedings.

[9]  J. Boullata,et al.  Elevated arterial blood pressure in survivors of liver transplantation treated with cyclosporine and corticosteroids. , 1988, Transplantation proceedings.

[10]  D. Niederwieser,et al.  Successful engraftment of high-risk corneal allografts with short-term immunosuppression with cyclosporine. , 1988, Transplantation.

[11]  R. Nussenblatt,et al.  Renal histopathologic alterations in patients treated with cyclosporine for uveitis. , 1986, The New England journal of medicine.

[12]  F. Hoffmann,et al.  Lokale Behandlung des Hornhauttransplantates beim Menschen mit Cyclosporin A , 1985 .

[13]  J. Chandler,et al.  Corneal allograft rejection. The role of the major histocompatibility complex. , 1983, Survey of ophthalmology.

[14]  G. Foulks,et al.  Beneficial effects of histocompatibility in high-risk corneal transplantation. , 1982, American journal of ophthalmology.

[15]  T. A. Bell,et al.  A placebo-controlled blind trial of cyclosporin-A in prevention of corneal graft rejection in rabbits. , 1982, The British journal of ophthalmology.

[16]  A. Garner,et al.  Corneal graft rejection: a new rabbit model and cyclosporin-A. , 1982, The British journal of ophthalmology.

[17]  J. D. Salisbury,et al.  Suppression of corneal allograft rejection by cyclosporin A. , 1981, Archives of ophthalmology.

[18]  D. Coster,et al.  Effect of cyclosporin A on the survival of corneal grafts in rabbits. , 1980, The British journal of ophthalmology.

[19]  D. Coster,et al.  PROLONGED SURVIVAL OF CORNEAL ALLOGRAFTS IN RABBITS TREATED WITH CYCLOSPORIN A , 1979, The Lancet.

[20]  J. Schuppler,et al.  CYPROTERONE ACETATE , 1976, The Lancet.

[21]  J. R. Batchelor,et al.  HLA MATCHING AND CORNEAL GRAFTING , 1976, The Lancet.

[22]  S. I. Brown,et al.  A follow-up report on transplantation of the alkali-burned cornea. , 1974, American journal of ophthalmology.

[23]  Alex E. Krill.  Symposium on Ocular Therapy , 1970 .

[24]  P. Colombani,et al.  Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation. , 1988, Transplantation proceedings.

[25]  Y. Pouliquen,et al.  [Cyclosporin A eyedrops in the prevention of high-risk corneal graft rejection. II. Postoperative clinical results]. , 1987, Journal francais d'ophtalmologie.

[26]  J. Arentsen.  Corneal transplant allograft reaction: possible predisposing factors. , 1983, Transactions of the American Ophthalmological Society.